Among HIV-infected persons who develop tuberculosis before starting ART and have < 50 CD4+ lymphocytes/mm3 at the time of tuberculosis diagnosis, starting of ART within 2-4 weeks of initiating anti-tuberculosis therapy significantly improves survival [5,6,7]. This evidence concerns the gene CD4 and tuberculosis.